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Abstract
Background: The ‘three delays model’ attempts to explain delays in women accessing emergency obstetric care as the
result of: 1) decision-making, 2) accessing services and 3) receipt of appropriate care once a health facility is reached. The
third delay, although under-researched, is likely to be a source of considerable inequity in access to emergency obstetric
care in developing countries. The aim of this systematic review was to identify and categorise specific facility-level barriers
to the provision of evidence-based maternal health care in developing countries.
Methods and Findings: Five electronic databases were systematically searched using a 4-way strategy that combined
search terms related to: 1) maternal health care; 2) maternity units; 3) barriers, and 4) developing countries. Forty-three
original research articles were eligible to be included in the review. Thirty-two barriers to the receipt of timely and
appropriate obstetric care at the facility level were identified and categorised into six emerging themes (Drugs and
equipment; Policy and guidelines; Human resources; Facility infrastructure; Patient-related and Referral-related). Two
investigators independently recorded the frequency with which barriers relating to the third delay were reported in the
literature. The most commonly cited barriers were inadequate training/skills mix (86%); drug procurement/logistics
problems (65%); staff shortages (60%); lack of equipment (51%) and low staff motivation (44%).
Conclusions: This review highlights how a focus on patient-side delays in the decision to seek care can conceal the fact that
many health facilities in the developing world are still chronically under-resourced and unable to cope effectively with
serious obstetric complications. We stress the importance of addressing supply-side barriers alongside demand-side factors
if further reductions in maternal mortality are to be achieved.
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Introduction
The massive difference in the maternal mortality ratio (MMR)
between rich and poor countries is one of the largest disparities of
any public health statistic, including under-five mortality [1].
While there has been real progress in reducing mortality rates in
children under five [2], the reduction in MMRs has fallen well
short of the Millennium Development Goal 5. Paradoxically, it is
not for a lack of effective, evidence-based interventions that this
problem persists. The World Health Organization estimates that
at least 88–98% of maternal deaths can be averted with timely
access to existing, emergency obstetric interventions [3].
The majority of maternal deaths are clustered around labour,
delivery and the 24 hours postpartum [4,5]. It is estimated that just
5 conditions (postpartum haemorrhage; puerperal sepsis; pre-
eclampsia and eclampsia; obstructed or prolonged labour, and
complications of unsafe abortion), account for at least 60% of all
maternal mortality [6]. Life-threatening situations may develop
rapidly and without warning, often in previously uncomplicated
pregnancies. It is because of the unpredictable nature of childbirth
that emergency obstetric care (EmOC) has been called the
‘keystone in the arch of safe motherhood’ [7].
A number of factors can influence a woman’s ability to access
effective interventions to treat such complications in the event of
an obstetric emergency. In their seminal 1994 paper, Thaddeus
and Maine group these into three broad categories using a classic,
pathways-based framework [8]. Known as the ‘three delays
model’, it has been used extensively in studies of maternal
mortality in developing countries (Figure 1).
Since 1994, numerous studies have identified significant Phase I
and II ‘demand-side’ barriers (delays in the decision to seek care,
and in identifying and reaching a medical facility) that prevent
women in developing countries utilising and accessing delivery
services. These have been summarised in three systematic reviews
[9,10,11].
In the wider global health context, there is a growing body of
literature on the impact of different health system interventions on
health services quality, utilisation and outcomes. The WHO
describes six ‘‘building blocks’’ for strengthening health systems:
service delivery, health workforce, information, medicines, financ-
ing and governance [12]. The emergent field of implementation
research has also produced several important reviews on how best
to bridge the gap between evidence and practice [13,14,15].
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Despite these important contributions, no systematic review has
dealt comprehensively with the health systems delays that prevent
the receipt of timely and appropriate obstetric care once a woman
reaches a health facility (Phase III delays). These ‘supply-side’
barriers (for example, lack of adequately trained personnel and
difficulties procuring essential drugs) are often major factors
contributing to maternal deaths in developing countries.
In this paper we focus on Phase III delays, which, although
previously neglected, are likely to be a source of considerable
inequity in access to emergency obstetric care. A better
understanding of the relative importance of barriers that
contribute to Phase III delays could lead to improvements in the
quality of obstetric services for women in developing countries.
Methods
We undertook a systematic review to identify facility-level
barriers to the provision of evidence-based, maternal health care in
low-income settings, and to identify attempts that have been made
to assess the relative importance of these barriers in different
settings.
We searched 5 electronic databases (PubMed, CINAHL, CABI
Global Health, Global Health Library (Medline) and WHO
Publications) from 1994 to 2010 to identify original research
articles using a 4-way strategy. We combined search terms (and
synonyms) related to: 1) maternal health care (e.g. obstetric care,
perinatal care, maternal health services); 2) facility-level (e.g.
maternity unit, health facility, Phase III, hospital); 3) barriers (e.g.
treatment delay, obstacle, shortage, quality of care), and 4)
developing countries (e.g. low-income countries, Africa, Asia,
Latin America). The search strategy is available in Appendix S1.
A total of 3,375 papers were retrieved and imported into
reference management software (RefWorks, Bethesda, USA).
Fifteen additional records were identified from other sources,
including a manual search of reference lists of key articles and
expert recommendations. After removing duplicates, one investi-
gator (HK) independently screened titles and abstracts to identify
candidate articles (n = 53). Articles were shortlisted if the title and
abstract indicated that they reported the results of original
research studies in the English language using quantitative,
qualitative or mixed method approaches. Articles were also
required to have been undertaken in developing countries and
to report the association between delays at the facility level and
maternal mortality or severe morbidity. Articles were also
excluded if the research solely examined patient-side or commu-
nity-level barriers leading to treatment delays, or if only the clinical
causes of maternal death were reported. Research published or
including data collected before 1994 was excluded, because the
‘three delays’ model was first published in this year, and because
the rapid development of maternal health care in the 1990 s
reduced the relevance of data from earlier decades.
Two investigators (HK and AS) then independently reviewed
all full-text candidate articles for eligibility. A third investigator
(SK) resolved any differences. Ten of the candidate articles were
excluded: eight did not report original research (5 were
commentary pieces [8,14,16,17,18]; 3 proposed new evaluation
instruments [19,20,21]; one dealt with barriers to evidence-
based interventions for normal labour [22], and one reported
improvements in the quality of maternity care as a result of an
intervention without reporting baseline barriers [23]. Forty-three
full-text, original research articles were included in the final
selection
[24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44-
,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65-
].
A qualitative approach was used to develop a data extraction
framework. Thematic analysis techniques were used to identify
and categorise barriers into emerging themes. Starting with a
selection of the richest texts, two investigators (HK and AS)
recorded all barriers either implicitly or explicitly cited in articles
as being responsible for facility-level treatment delays. Barriers that
were closely conceptually related were merged. For example, some
articles referred to clinical guidelines being out of date or
ambiguously worded: these barriers were both classified as
‘inadequate content of clinical guidelines’. In contrast, barriers
related to poor dissemination or poor enforcement of guidelines on
the labour ward were classified as ‘inadequate dissemination of
clinical guidelines’.
Figure 1. Three Delays Model.
doi:10.1371/journal.pone.0063846.g001
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(Figure 2)
The investigators used the data extraction tool to independently
extract the following information from each article: country/ies,
type of study (quantitative, qualitative or mixed), methodology
(survey, interview, other), sampling strategy, number of facilities/
districts covered, interventions covered, and barriers identified,
including whether attempts were made to quantify the barriers. A
third investigator (SK) resolved any differences.
We identified 32 conceptually unique Phase III barriers, which
were categorised into 6 emerging themes (Drugs and equipment;
Policy and guidelines; Human resources; Facility infrastructure;
Patient-related and Referral-related). Although some authors
classify referral barriers as primarily transport-related and
therefore Phase II delays, we consider these Phase III barriers
since a well-functioning network of primary care integrated with
hospital services is a key important component of health service
delivery [66]. The frequency with which each barrier was
explicitly reported was recorded so as to map trends in the
literature (Table 1; Appendix S2). In addition, the reviewers
recorded separately any references to factors that they interpreted
as being barriers, even if they were not explicitly stated as such by
the authors. These were then discussed with the third reviewer
(SK) and reported as ‘implicit barriers (Table 1, column 3).
Results
Of the 43 studies included in the review, 30 were conducted in
Africa, 4 in Asia, 4 in Latin America, and 5 in more than one
region. The research methods used were quantitative (n = 15),
qualitative (n = 9) and mixed (n = 18). Methodologies used to assess
Phase III barriers included surveys of healthcare practitioners, in-
depth interviews with stakeholders, focus groups, facility-based
audits, district-based maternal mortality reviews, and needs
assessments based on indicators and signal functions.
Human Resources
Human resource issues were the most common barriers
reported across the literature, mentioned by 41 of the 43 papers.
Within this category, it would seem the greatest problems relate in
one way or another to training of personnel, as this barrier was
cited in 37 articles. There were several accounts of inadequate
training resulting in fatalities or near-miss events. One woman,
after being admitted with haemorrhagic shock, waited 36 hours
before her abdominal pregnancy was diagnosed at laparotomy
[24], Several studies reported that educational opportunities for
health workers were overwhelmingly deficient due to the absence
of continuing education programmes, adequate formal training
and a habit of self-learning, as well as poor access to up-to-date
educational resources [49,53] [27,61]. A Cameroonian midwife
taking part in one of the studies remarked: ‘‘I am just happy with these
few minutes we have spent today because for me this is my midwifery revision
after 34 years’’. She was the midwife in charge of a district hospital
maternity unit [53].
The next most cited barriers were staff shortages, referenced in
26 articles, followed by staff motivation issues. Nineteen papers
stated that low motivation caused delays. In one hospital in Coˆte
d’Ivoire, the good will of administrative staff was a major factor in
whether or not surgical kits could be purchased on credit for
critically ill patients, despite the pleas of doctors [24]. Staff were
Figure 2. Identification, screening, and inclusion of articles.
doi:10.1371/journal.pone.0063846.g002
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variously identified as overworked and underpaid; [41] misusers of
limited health resources for private practice [31]; lacking
motivation to change the way they practise [49]. and down-right
dishonest [42,50]. Motivation levels often affected the availability
of staff. Both doctors [29] and midwives [27] were found to be
more motivated by their private practices, with low wages and
poor conditions incentivising staff to work elsewhere, often in cities
rather than rural communities [48]. One paper stated: ‘‘the staff had
such a low salary that they could not concentrate on their work, but had to
spend most of their time in income generating activities’’. Such poor
motivation was confirmed by medical officers as an important
contributor towards poor patient management [54] and one article
recommended that extra incentives should be put in place to retain
staff in rural or marginalised areas [48].
Eleven of the articles suggested that 24-hour availability of staff
was inadequate. Staff shortages and absenteeism almost certainly
contributed towards cases of sub-optimal supervision (ten articles)
and high workloads (six articles). Staff shortages were often
compounded by managerial issues. In Gondar, Ethiopia, the
region’s only obstetrician was often taken from the wards to teach
and examine trainees [49], whilst in rural Gambia only one doctor
Table 1. Frequency of Phase III barriers reported in articles.
Explicit barriers count
(max =43)
Implicit barriers count
(max =43) Grand Total
Human Resources 40 1 41
Staff shortages 19 7 26
Issues related to quality of training/skills mix 33 4 37
Staff motivation issues 16 3 19
Inadequate supervision 5 5 10
High workload 5 1 6
Authorisation to perform certain tasks 2 2 4
Absenteeism 1 1 2
24-hour availability of staff 8 3 11
Management issues 3 0 3
Drugs and Equipment 33 5 38
Cost issues 7 1 8
Inadequate drug supply/logistics problems 26 2 28
Lack of appropriate storage (e.g. fridge/secure cabinet) 2 3 5
Not on essential medicines list/registered for indication 3 0 3
Lack of equipment 18 4 22
Equipment available but not used/faulty 5 1 6
Lack of blood 13 0 13
Guidelines/Policy 25 4 29
Inadequate content of clinical guidelines 7 1 8
Inadequate dissemination of clinical guidelines 6 3 9
Poor hospital policy/record keeping 14 0 14
Preference of staff for non-evidence based treatment/s 8 2 10
Facility Infrastructure 17 8 25
Lack of beds/ward space 2 2 4
Power/water shortages 8 1 9
Surgical facilities 6 10 16
Transfusion facilities 6 2 8
Laboratory facilities 1 1 2
Referral 14 2 16
Distance-related 3 3 6
Road infrastructure 0 2 2
Inadequate emergency transport 12 0 12
Fuel availability 3 0 3
Poor communication 4 1 5
Patient-side 13 0 13
Cost-related 8 0 8
Social/cultural/religious 5 1 6
doi:10.1371/journal.pone.0063846.t001
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remained on the unit because the other three had been allowed to
go on leave at the same time [42].
Drugs and Equipment
Issues relating to the availability of essential drugs, equipment
and blood were cited in 38 articles. Twenty-eight articles referred
specifically to inadequate supply and distribution of drugs and
equipment, compared with only eight that mentioned cost as a
prohibitive factor. Twenty-two articles referred to essential
equipment that was lacking altogether (including surgical equip-
ment and vacuum aspirator pumps), as well as very basic
equipment such as surgical gloves and cannulae. A further six
articles made reference to existing equipment that was either
broken or poorly maintained.
Lack of safe blood supplies for transfusion was also a major
problem identified in 13 articles. In one Nigerian tertiary hospital
over 20% of the maternal deaths were due to delays in acquiring
blood [47]. In some cases, blood had to be obtained from hospitals
that were several kilometres away [24]; had to be bought by the
family at great expense [42,50], or donated by relatives or friends
[43]. Family members were often expected to embark on journeys
to obtain blood products [27], sometimes taking several days [42].
Five articles stated that appropriate storage facilities for drugs
and blood were not available, and so products became spoiled due
to storage at incorrect temperatures. A national survey in
Tanzania found that uterotonic drugs (which should be kept
refrigerated) were stored at room temperature in 28% of the
facilities [46]. During an interview, one Gambian woman
recounted, ‘‘My husband managed to buy two bottles of blood for me
yesterday. The morning ward staff collected the blood from the lab and put them
on top of the ward refrigerator for cooling. The following morning my husband
was again told to replace the two bottles as the previously acquired blood was
‘spoiled’ as the nurse put it’’ [43].
Finally, in three articles, key drugs were either missing from the
country’s ‘essential medicines list’, or not registered for a particular
indication. This was a particular issue for magnesium sulphate.
For example, in one study, the drug was not licensed for the
treatment of pre-eclampsia in 7 out of 13 low-income countries
[34]; in Zimbabwe, it had not been registered for use at all [52].
One reason offered was that the low cost of the drug removes any
incentive on the part of manufacturers to maximize its use [52].
Guidelines/policy
Twenty-nine of the papers identified inadequate clinical
guidelines or poor policy environment as a factor contributing to
sub-standard maternal care in the population being studied. Issues
relating to poor policy at the level of the individual facility (for
example, bad record keeping) were reported in 14 articles. One of
the most common examples of poor policy at the hospital level was
the lack of partogram use, which was specifically mentioned in five
articles [49,58,61,64,65]. In one hospital, staff understood the
importance of using partograms to monitor the progression of
labour but were left to make their own bespoke charts in the
medical notes as the hospital did not supply them [49]. Another
example was cited in Nairobi, where a policy which dictated that
all patients must obtain antenatal cards and pay cash deposits
before being eligible for delivery services led to recurrent
treatment delays [58].
The inadequate content and dissemination/enforcement of
national clinical guidelines was mentioned in eight and nine
articles, respectively. The article by Aaserud et al. found that
national clinical guidelines for pre-eclampsia were absent in eight
out of 13 low and lower-middle income countries, leading to a
failure to provide magnesium sulphate when necessary. Those
based in Latin America expressed a contrary concern: the over-use
of magnesium sulphate in situations in which it was not supported
by the latest research, similarly indicating a failure to disseminate
best-practice guidelines effectively [34].
Ten articles also reported that staff preferred to use less effective
or non-evidence based interventions. These included a preference
for expectant rather than active management of the third stage of
labour [46]; treatment of eclampsia with diazepam [51] [53];
routine use of enemas [44], and a lack of compliance with
recommendations to deliver HIV positive women routinely by
Caesarean section [49]. In the article from Cameroon, one
medical officer was quoted as saying ‘‘I not only don’t do it [external
cephalic version (a recommended practice for breech presentation at term)]; I
actively discourage it because it is very dangerous’’ [53].
Facility Infrastructure
Poor hospital infrastructure was identified in 25 articles and the
most frequent barrier explicitly reported within this category was a
shortage of power and/or water. Nine papers stated that such
shortages delay treatment in emergency situations.
Orji et al. concluded that the major factor causing delay to
treatment is theatre-related [47]. Indeed we found six studies,
which explicitly stated that theatre space and surgical facilities
were a problem and a further ten that implied this. Not all
hospitals have a theatre but even in those that do, surgical services
may be irregular and not accessible 24 hours per day. Delays
understandably occur when theatres are already being used, but
even when extra theatre space is made available it is not always
possible to mobilise staff and so treatment is delayed [24].
Another delay related to transfusion facilities. Many articles
stated that the lack of blood delayed treatment, but eight papers
found that a number of hospitals did not even have a blood bank.
In one paper, only 9% of the district hospitals in Dar Es Salaam
had a blood bank [54] and the proportion in another article
looking at obstetric care in poor regions of Ghana, India and
Kenya found equally poor availability [58]. Bed/ward space and
laboratory facilities were less commonly problematic, with only
four and two citings respectively.
Referral-related Factors
It is alarming that even when conditions are identified that
require more sophisticated care, providers are sometimes unable
to, or worse, unwilling to arrange referrals. Indeed one patient was
not referred because of her HIV positive status [41]. Twelve of the
16 articles that highlighted referral-related issues reported that
inadequate emergency transport contributed towards maternal
mortality. Various reasons were cited such as the ambulance - had
broken down and there was no replacement [42]; was being used
for an alternative purpose [33], or was under-staffed and ill-
equipped [27]. Car ambulances were only available in 7–31% of
facilities in three districts of Malawi [28]. Further delays occurred
in three of the papers because the ambulance had no fuel
[33,41,42], meaning at times that the woman’s relatives had to be
sent to purchase more [42].
Eight articles mentioned difficult journeys mothers undergo
when referred to higher levels of care. Distances between facilities
can often be great and the roads themselves poor. One article
described the regional hospital as ‘‘about 2 hours away on paved
roads’’ [41]. It was also noted that communication between
facilities can be sub-standard. Five articles stated that communi-
cation was an issue because of non-functioning radios and
telephones or a complete lack thereof.
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Patient-side Factors
Thirteen articles reported that patient-side barriers contributed
to maternal deaths once women reach a medical facility. Eight
articles cited cost-related factors related to compulsory user-fees
that hospital staff demand prior to providing treatment/surgery,
particularly in relation to emergency Caesarean section. Religious
beliefs and negative socio-cultural attitudes towards biomedicine
were believed to impede the use of certain medical interventions in
six articles. These interventions included HIV testing and
administration of peripartum antiretroviral treatment, compan-
ionship during labour because of concerns about witchcraft,
privacy and gossip [53], and taboos surrounding blood donation
that prevented family members from providing or obtaining blood
supplies for emergency transfusion [29,59].
Discussion
Although there is a relatively large body of literature on health
systems barriers in high-income country contexts, the same cannot
be said of low-resource settings. By systematically searching 5
electronic databases for original research articles we identified 43
articles that examine Phase III delays in maternal health care in a
developing country context. The five most commonly cited
barriers were inadequate training/skills mix (86%); drug procure-
ment/logistics problems (65%); staff shortages (60%); lack of
equipment (51%) and low staff motivation (44%) (Table 1).
Several of the studies included in this review aimed to assess the
relative impact of the three phases of delay on maternal mortality.
In some studies, Phase III delays contributed significantly more to
maternal mortality than both Phase I and II delays. In a facility-
based audit in Tigray, Ethiopia, 88% of the maternal deaths could
be attributed to medical failures [30]. In a hospital-based case-
control study of maternal mortality in Southern Nigeria, ‘‘the most
striking difference between the [maternal mortality and control]
groups was in the Phase III delays’’ [25]. In another facility-based
maternal death review in Malawi, 20 out of 28 maternal deaths
were associated with healthcare worker factors, and a further 6
with administrative failures [62]. Moreover, these findings are not
unique to facility-based studies. In a district-based audit in
Indonesia, 60% of maternal deaths involved a Phase III delay.
[26] In a cohort study of pregnant Haitian women from 10 rural
districts, inadequate care at a medical facility was a factor in 7 of
the 12 maternal deaths that occurred [41]. Finally, an audit into
maternal deaths in a Zimbabwean province found that 87% were
avoidable; of these, 57% involved the heath services and 33%
patient-related delays [67]. The findings of these studies are
supported by the 2005 WHO World Health Report, which
estimated that access to good obstetric care could prevent 50–70%
of global maternal deaths and substantially reduce the number of
women living with sequelae of obstetric complications [68].
The most commonly-identified Phase III barriers identified in
this review are related to human resources. Shortages in
healthcare personnel are a problem across all health sectors and
all levels of training in most of the developing world. The global
shortfall is on a massive scale: WHO estimates over 800,000
additional doctors and nurses are required to address current
demand [69]. In the field of nursing, there is as much as a
hundredfold difference in the nurse to population ratio between
some African nations and the United States [70]. Maternal
healthcare is no exception: according to a United Nations report,
published in 2008, only 47% of deliveries in Sub-Saharan Africa,
and 40% in Southern Asia, took place in the presence of a doctor,
nurse or midwife [71]. Key reasons include worker shortage,
maldistribution, skill mix imbalance, negative work environment,
and poor access to in-service training. In many low-income
countries, the health workforce is being severely affected by HIV/
AIDS, inadequate government investment, and the ‘brain drain’
phenomenon [72]. These barriers will need urgently addressing in
order to see further reductions in maternal mortality.
Strengths and Limitations
There were several limitations to this systematic review. First, a
number of rich sources of information about the third delay may
have been missed, for example unpublished facility-based audits
and confidential enquiries into maternal deaths. Although we
sought expert opinion to identify key publications in the grey
literature, our search strategy largely identified articles published
in peer-reviewed journals. Since many journals have an explicit
policy of not publishing audits, a considerable amount of
information about Phase III delays may have been missed.
Another problem encountered was related to defining appro-
priate search terms that would identify all articles relating to Phase
III delays. For example, very few medical subject headings
(MeSH) were available for treatment delays at the facility level.
Instead, free-text search terms had to be developed. Articles about
facility-level barriers to the provision of maternal health care do
not necessarily refer explicitly to the ‘third delay’ or use other
easily predictable terminology. Moreover, there are so many wide-
ranging barriers that could impact upon the quality of obstetric
care, that it was not possible to anticipate all possibilities in our
search strategy. The sheer breadth of the topic means that some
important original articles may have been missed. Despite these
problems, we believe that although the overview of factors
provided in this review is unlikely to be completely exhaustive of
the literature on each barrier it is nonetheless a comprehensive
review of the categories of barrier that contribute to Phase III
delays.
A key challenge related to data extraction was that was that
barriers were often poorly defined: for example, many of the
articles attributed maternal deaths to the ‘lack of’ a specific drug or
resource. With a few exceptions [24,34,52], the reasons underlying
the poor availability or health commodities were not explored in
any depth, making it difficult to classify whether the poor
availability was due to cost, supply and distribution, or a
combination of factors. Another common problem encountered
was the ambiguity of the phrase ‘a shortage of adequately trained
staff.’ Is the emphasis here on the number of personnel or the
quality of their training, or both? For consistency, in such
instances, we decided to record training as an explicit barrier and
staff shortage as an implicit barrier.
In some articles, the root cause of poor quality of care was left
entirely unexplained. For example, one article cited the case of a
woman with diagnosed hand presentation who needed an
emergency Caesarean section, yet was left for over 48 hours
before having surgery. The authors gave no reasons as to why was
she not attended to sooner by staff despite a correct diagnosis [42].
Was it a case of staff lacking the training to know that they should
intervene? Was the doctor unavailable? Could the woman simply
not afford to pay for the operation? Or were there other factors at
work? We chose to document barriers separately that were implied
in the text, but not clarified or discussed explicitly (Table 1,
column 3).
The quality of the research in many of the articles was
methodologically weak. Several papers also failed to explain their
methodology adequately, yet made relevant observations that were
worthy of comment. Whilst there are clear tools for the assessment
of randomized controlled trials and other experimental studies,
there is little guidance concerning analysis of the quality of
A Systematic Review of the Third Delay
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qualitative observational studies. Although several assessment
scales and checklists have been used [73,74], they have not been
validated and are inappropriate for non-intervention studies; thus,
we included all studies that met the inclusion criteria, regardless of
the quality of the quality of the methodology.
The results of this systematic review may be influenced by study
bias: that is, the authors of the articles included in the review may
have chosen (intentionally or otherwise) to investigate or report
certain types of barrier over others, depending on their particular
area of interest. Although current knowledge is very limited with
regard to the influence of bias on systematic reviews without meta-
analyses [75], we acknowledge that the frequency of barriers
presented here are not necessarily representative of the ‘‘true
frequency’’ of barriers in the developing world. The synthesis of
results from the reviewed articles (i.e. the frequency counts in
Table 1) should be interpreted with some caution, and not
extrapolated to represent the true magnitude or relative impor-
tance of the various barriers in the developing countries.
The results of the articles are in fact very hard to compare due
to the differences in study design, sampling strategy and the
analysis techniques employed. Furthermore, context specificity
means that synthesis is extremely problematic. As Gabrysch and
Campbell highlight in their review of Phase I and II delays [9]:
‘‘Even if all methods were identical, it would be naı¨ve to expect the effect
of, say, distance in Malawi and Peru to be the same, given that
infrastructure, transport options, education level, norms around place of
delivery and many other factors differ.’’
As this review highlights, a highly complicated web of reasons,
many of which are interdependent, can be used explain treatment
delays, ranging from behavioural factors such as staff motivation to
material factors such as the availability of specific resources. Many
of these factors are hard to measure, often go unreported, and are
therefore extremely hard to control for to allow context to be taken
into account when synthesising results.
Finally, information about which barriers are more or less
important to the provision of high quality care was rarely given in
the articles reviewed. With the exception of one article [45],
studies did not attempt to assess the magnitude of barriers in the
local context. This type of assessment would be useful for both
short- and long-term priority setting purposes. Efforts to incorpo-
rate cost-effectiveness into assessments would also be valuable.
Implications and Recommendations
From an economic perspective alone, global maternal health
outcomes would be greatly improved if ways to overcome obstacles
to the widespread use of currently available interventions could be
found. This review highlights the importance of addressing both
supply-and demand-side barriers in any effort to reduce maternal
mortality. The studies included document the severity of facility-
level failures and serve to highlight that a focus on patient-side
delays can sometimes conceal the fact that many health facilities in
the developing world are still chronically under-resourced and
cannot cope effectively with serious obstetric complications.
Moreover, as Thaddeus and Maine state in their original article,
the ‘‘three phases of delay rarely operate in isolation…indeed the
factors are likely to be interactive and multiplicative. Thus,
barriers and poor care encountered at Phase II and III feed back
into subsequent decision-making at Phase I’’ [8]. For this reason,
Phase III barriers are likely to influence decisions to seek care and
impact not only on maternal mortality at the facility-level, but also
on maternal deaths in the community.
The focus in the past few decades on encouraging a shift from
home-based to institutional delivery will have been misplaced if
efforts to improve the quality of care a woman receives once she
comes through the doors of a health facility is not stepped-up.
Indicators such as the ‘time from arrival to definitive treatment’
[76] or the ‘percentage of women with obstetric complications
treated within two hours at a health facility’ [77] have been
proposed. However, few studies reported these outcomes as the
data are rarely available from routine medical records [24]. We
agree with those who call for the introduction of benchmark
indicators that assess the content and quality of maternal care, rather
than the rates of skilled attendance at birth alone [78].
Simple, replicable tools to assess facility-level barriers are badly
needed to assist health managers in identifying facilities that
deliver sub-optimal care, and in both making and monitoring the
required improvements. No generally accepted methodology exists
and this makes comparisons between countries very difficult [19].
We commend efforts by Pitchforth et al. [49] to incorporate social
science methodology into these evaluations, as using mixed-
method designs may yield more useful results.
To ensure that information on barriers to high quality, effective
care contributes to improved responsiveness to emergencies,
specific reasons for delays in providing particular interventions
must be identified. We have recently completed a large-scale
survey of direct maternal healthcare providers in 99 developing
countries in an attempt to link specific Phase III barriers to a range
of recommended interventions, and to identify locally-appropriate
solutions [79].
Conclusions
This review highlights how a focus on patient-side delays in the
decision to seek care sometimes conceals the fact that many health
facilities in the developing world are still chronically under-
resourced and unable to cope effectively with serious obstetric
complications. A wide range of facility-level barriers to EmOC are
in operation which result in thousands of avertable deaths
worldwide. At present, facility-level barriers are often not reported
in sufficient detail in research studies evaluating the quality of
maternal healthcare. This makes finding solutions very difficult.
We stress the importance of addressing supply-side health systems
barriers alongside demand-side factors if further reductions in
maternal mortality are to be achieved. The development of simple,
replicable tools to assess facility-level barriers should be seen as a
priority for future research. The availability of such tools would
assist health managers in identifying facilities that deliver sub-
optimal care, and in both making and monitoring the required
improvements.
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